Project Clay, co-founded by Dyumna Madan and Shivom Sood, impressed on Shark Tank India 4, securing investment from Namita ...
Namita Thapar, Shark Tank India Investor and Executive Director of Emcure Pharmaceuticals - has sparked a major discussion on ...
Speaking on the association, Namita Thapar, whole-time director, Emcure Pharmaceuticals, said, “We are excited to partner with Vidya, as she is bold, authentic, and truly embodies what our brand ...
In a groundbreaking pitch on Shark Tank India, Nandita Yenagi and Sharad Patil ... highlighting its ability to deliver a shock of up to 4000 volts. However, Namita Thapar raised concerns about the ...
In this session of #indiatodayconcalve Shark Tank India's Namita Thapar discusses the impact of television in educating viewers through storytelling. She highlights how the show has given respect ...
Emcure Pharmaceuticals’ Whole-Time Director and Shark Tank India judge, Namita Thapar, recently shared her personal experiences of being bullied during her childhood. Namita Thapar shared her ...
A couple of young entrepreneurs pitched their fitness app business on Shark Tank India, which is currently airing its ... which the founders weren’t in favour of. Namita Thapar jumped in, and said ...
Sonakshi Sinha and Zaheer Iqbal will discuss relationships and personal life. Namita Thapar, executive director of Emcure Pharmaceuticals, Avarna Jain, vice chairperson of Saregama, and Anu Ranjan ...
An emotional episode of ‘Shark Tank India 4’ saw judges Kunal Bahl and Namita Thapar sharing their experiences of being bullied for their weight. They were moved by the pitch of Fitelo, a fitness app ...
Shark Tank India Season 4 has kept the viewers enthralled with ... The pitch prompted Sharks Kunal Bahl and Namita Thapar to come out about their difficulties. In the recent episode, as the founders ...
The latest episode of Shark Tank India 4 featured three compelling ... conversation about the lasting impact of body shaming. Namita Thapar then opened up about her own painful experiences with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results